Huma

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Investment firmhuma.financeSince 2026-09-23

ROUNDS

as lead investor

LED ROUNDS · USD

$0K

no led round states an amount · 1 co-led, split evenly

LATEST ROUND

Series A · 2026-09-23

CO-INVESTORS

named beside it

Rounds

[ 1

The rounds this investor is named on, who it invests beside, and where it shows up.

A clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors

Series An/a2026-09-2311

Company	Round	Amount	Announced	Role
ViferaXS A clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors	Series A Verified against 4 of 11 sources	up to €12M incl. grants	2026-09-23	[ LEAD ]